Searchable abstracts of presentations at key conferences in endocrinology

ea0090p589 | Calcium and Bone | ECE2023

Denosumab for Osteoporosis in Patients With Primary Hyperparathyroidism in a Tertiary Hospital in Spain

Alexandra Zapata Maldonado Gabriela , Isla Alberto , Piedra Maria , Ramos Ramos Laura , Vazquez Luis

Introduction: Osteoporosis is a frequent complication associated with primary hyperparathyroidism (PHPT), and surgery is the most effective treatment once established. However, many patients are not candidates for it, and different medical options have been investigated. We aimed to assess the efficacy of denosumab (DMAB) in increasing bone mineral density (BMD) and preventing PHPT-related complications.Methods: Case-control study defining cases (Group 1...

ea0090p363 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

Bulimia Investigatory Test of Edinburgh (BITE) use in an endocrinology outpatient clinic

Alexandra Zapata Maldonado Gabriela , Gonzalez-Villa Maria , Luis Talledo Madrid Pedro , Ines Simbana Aragon Gabriela , Alcantara-Aragon Valeria

Objectives: To evaluate the prevalence of eating disorders (ED) at an Endocrinology outpatient clinic (EOC); with the use of Bulimia Investigatory Test of Edinburgh (BITE).Methods: Descriptive analysis of clinical characteristics and BITE scores from patients with suspicion of ED at a first appointment in an EOC with an average of 128 new patients/year. Data was collected from January-2021 to December-2022. The main suspicion criteria were: self-reported...

ea0090p729 | Reproductive and Developmental Endocrinology | ECE2023

Sex hormones as independent predictors of severe COVID-19 in patients with SARS-CoV-2 infection

Quinzanos Ruiz Cristina , Alexandra Zapata Maldonado Gabriela , Teresa Garcia-Unzueta Maria , Vazquez Luis , Alio Lavin Gomez Bernardo , Ruiz Ochoa David

Introduction: The SARS-CoV 2 pandemic has resulted in millions of deaths worldwide. It has been suggested that sex steroids may be involved in the prognosis of the disease.Material and methods: Male patients diagnosed with SARS-CoV-2 infection admitted to the Marqués de Valdecilla University Hospital (Spain). Testosterone, androstenedione, estradiol, DHEA and DHEAS were determined in the first 24 h of admission and severe COVID was defined as mortal...

ea0090p178 | Reproductive and Developmental Endocrinology | ECE2023

Are there Differences Between Androgens When Studying Androgenisation in the Transgender Patient?

Latorre Mesa Carlos , Velasco de Cos Guillermo , Villar Bonet Aurelia , Moyano Martinez Ana , Alexandra Zapata Maldonado Gabriela , Ormazabal Monterrubio Maialen , Alio Lavin Gomez Bernardo , Teresa Garcia-Unzueta Maria

Introduction: In gender affirming therapy of the transgender male, increasing doses of testosterone are administered and as the androgen dose increases, various biochemical parameters such as haematocrit, creatinine and PSA increase. It is not known whether any parameters have advantages in monitoring this androgenisation. Our study evaluates the correlation between the increase in androstanediol glucuronide, testosterone, free testosterone and free androgen index (FAI) with t...

ea0090p733 | Reproductive and Developmental Endocrinology | ECE2023

Periodic Assessment of Biochemical-Hematological Changes in A Series of Transgender Men After 1 Year of Gender Affirming Therapy

Velasco de Cos Guillermo , Latorre Mesa Carlos , Teresa Garcia-Unzueta Maria , Vazquez Luis , Ormazabal Monterrubio Maialen , Guerra Ruiz Armando , Moyano Martinez Ana , Alexandra Zapata Maldonado Gabriela , Villar Bonet Aurelia

Introduction: During gender affirming therapy in transgender men (TXM), androgens are administered at escalating doses. As therapy progresses, changes in various analytical parameters occur that may be of potential use in establishing a personalised androgen dosage and avoiding deleterious effects of the medication. The aim of our study was to study the evolution of different parameters throughout the course of gender affirming therapy.Material and metho...

ea0059p080 | Clinical practice, governance & case reports | SFEBES2018

Are we adhering to Simon Broome criteria for referrals for Familial Hypercholesterolaemia genetic mutation at Queen Alexandra hospital and are there any clear differentiators between the 2 outcome groups?

Parsad Meenakshi , Cummings Michael

Patients with Familial Hypercholesterolaemia (FH) have premature Cardiovascular disease and have a standardised mortality ratio nine times greater than normal. FH must therefore be correctly diagnosed and treated aggressively. Referral for FH is based on fulfilling the Simon Broome’s (SB) Criteria. We aimed to evaluate practice at Queen Alexandra Hospital with regards to referral for FH genetic mutation. We set out to see whether SB’s criteria were being fulfilled wh...

ea0016p235 | Diabetes and cardiovascular diseases | ECE2008

Cumulative incidence, timing and risk factors for thyroid dysfunction in 144 Romanian patients treated with amiodarone

Trifanescu Raluca-Alexandra , Fica Simona , Ion Oana-Gabriela , Coculescu Mihail

Aim: To assess cumulative incidence and risk factors for amiodarone-induced thyroid dysfunction (AITD) in a large cohort of Romanian subjects.Subjects and methods: One hundred and forty-four patients (59 M/85 F), mean age 61.4±0.9 years, treated 2.4±0.2 years with amiodarone were assessed for TSH, TT3, TT4 (immunoradiometric assays) and FT4, TPO Ab (microenzymatic immunoassays). Thirty-three patients were reside...

ea0070aep446 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

Real-time continuous glucose monitoring impact on the metabolic control over the summer in children with type 1 diabetes

Gabriela Duta Simona , Bojoga Irina , Ruxandra Calapod Ioana , Marin Alexandra , Malinici Elisabeta , Ioacara Sorin , Fica Simona

Background: Type 1 diabetes is a chronic disease requiring constant management and a disciplined lifestyle, especially in children. Real-time continuous glucose monitoring system (RT-CGMS) can be a useful tool in maintaining good glycemic control. In our medical centre, beginning with January 2019, a National Program for free distribution of RT-CGMS has been set in motion. The results from one of our previous studies indicated a significant increase in glycosylated haemoglobin...

ea0070ep501 | Thyroid | ECE2020

Early diagnosis of acromegaly in chronic thyroiditis-case report

Stancu Ana-Maria , Gabriela Marin Alexandra , Beatrice Preda-Ivascu Monalisa , Mihai Daniel , Stancu Cristina , Badiu Corin

Introduction: Acromegaly is characterized by a pituitary adenoma with excess secretion of GH and IGF-1 hormones. More than 90% of the cases are diagnosed as macroadenomas, after 5 to 10 years of clinical manifestation.Case report: We present the case of a 49 years old man with minor thalassemia, hospitalized in endocrinology department for a routine check of chronic autoimmune thyroiditis. A careful anamnesis showed that in the last year the patient was ...

ea0090ep785 | Pituitary and Neuroendocrinology | ECE2023

Acromegaly and metabolic comorbidities – a retrospective study

Dumitras Teodor , Duta Simona Gabriela , Calapod Ruxandra , Bancu Alexandra , Nistor Irina , Sirbu Anca , Martin Sorina , Barbu Carmen , Fica Simona

Introduction: Acromegaly is a rare endocrine disease characterised by excess GH produced by a pituitary adenoma. It is associated with several complications and comorbidities. Metabolic alterations such as diabetes and dyslipidemia are quite frequent described in these patients.Materials and methods: This is a retrospective observational cross-sectional study meant to assess the metabolic modifications in a group of acromegaly patients evaluated in our d...